The main objective of this clinical is to get information on pharmacokinetics of zinc-enriched yeast.The bioavailability of the yeast enriched with zinc will be compared to two selected zinc salts used in food supplements that are zinc oxide and zinc gluconate.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
25
Comparison of pharmacokinetics parameters (AUC, Cmax and Tmax) between zinc-enriched yeast and zinc oxide.
Time frame: Baseline (0 min); 30; 60; 90;120; 150; 180; 210; 240; 300 and 360 min
Comparison of pharmacokinetics parameters (AUC, Cmax and Tmax) between zinc-enriched yeast and zinc gluconate.
Time frame: Baseline (0 min); 30; 60; 90;120; 150; 180; 210; 240; 300 and 360 min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.